Explore the burgeoning partnership between pharma and the NHS in developing large-scale data and research platforms. Learn how this collaboration is accelerating drug discovery, clinical research, and post-market surveillance. An essential insight into a critical aspect of modern healthcare development.
Dr Ameet Bakhai
Director Clinical Research, Royal Free London NHS FT
NHS whole working life, cardiology day job, R&D director local and national UKRD group, first CRIO at Royal Free passionate about research and all therapeutic innovations – drugs, devices (pacing and stents), diagnostics (biomarkers and wearables) and digital (AI predictive algorithms and data insights and clinical pathways). Have 1st ever Cerner heart failure pathway to nudge diagnoses (3-8x increased) and guidance prescribing (now top 10% adherence) and reduced mortality in hospital with 41,000 patient journeys data. Published >120 papers and used to observation to interventional research studies. recently on predicting arrhythmias and heart failure and now CVD from retinal imaging.
Commercial Director, DATA-CAN
Hassan is an entrepreneur and advisor in global digital health and innovation. He is interim Commercial Director for the UK’s Health Data Research hub for cancer (DATA-CAN) and was, until recently, the Global Digital Health Specialist for the Department for International Trade (DIT).
He is a founder at Opto Health, Vita and Inovia.Bio, Visiting Lecturer at UCL Global Business School for Health, Editorial Board Member of The International Journal of Digital Health, Mentor for the NHS Innovation Accelerator, Edison Accelerator and also at KQ Labs at The Francis Crick Institute, Commercial Consultant for Great Ormond Street Hospital for Children, Co-Chair of the HIMSS Innovation Committee for 2022 and a member of the HETT Steering Committee.
Dr Samin Saeed
Pharma Medical Leader
A medically qualified doctor by background, samin has been in the Pharmaceutical industry for 16 years, primarily leading Medical Affairs functions but has been involved in the UK clinical trials ecosystem, exploring how to recruit patients at scale in prior roles
Chair: Dr Danny Bosch
Associate Director of Business Development and Commercial, Imperial College Health Partners
Danny is Associate Director of Business Development and Commercial at Imperial College Health Partners and the Commercial Lead for the new Discover-NOW London SDE.
He is passionate about innovation and has a strong drive to make a meaningful impact to patients’ lives around the globe. He has over 10 years of experience in driving transformative growth and innovation across Life Sciences and is equipped with deep scientific expertise and global business experience spanning startups to corporations.
He is committed to paying forward by investing in the next generation of leaders as a Startup Mentor and Advisor for a range of accelerators, as Guest Lecturer at UCL Global Business School for Health and as an Angel Investor.